FDA Import Refusal AEK-8262872-6/11/1 — Abbvie Corporation
The FDA refused shipment AEK-8262872-6/11/1 from Abbvie Corporation (Canada) on Feb 25, 2025. The refused product falls under Drugs and Biologics — ADALIMUMAB. Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Feb 25, 2025
- Country
- Canada
- Product Category
- Drugs and Biologics
- Product Code
- 58SCK14 ADALIMUMAB
- Charges
- 75